Masimo Corporation
General ticker "MASI" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $8.3B (TTM average)
Masimo Corporation follows the US Stock Market performance with the rate: 12.2%.
Estimated limits based on current volatility of 0.1%: low 178.50$, high 178.81$
Factors to consider:
- Total employees count: 3600 (-5.2%) as of 2024
- US accounted for 53.8% of revenue in the fiscal year ended 2024-12-28
- Top business risk factors: Technology dependency, Market acceptance of new products, Integration of acquired businesses, Capital market access, Strategic risks and growth management
- Current price 23.8% above estimated high
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-03 to 2028-01-03
- 2026-01-03 to 2027-01-03 estimated range: [86.67$, 144.38$]
- 2027-01-03 to 2028-01-03 estimated range: [84.62$, 139.87$]
Financial Metrics affecting the MASI estimates:
- Negative: with PPE of 31.7 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 20.34 > 18.39
- Positive: Investing cash flow per share per price, % of 3.87 > -0.60
- Positive: Inventory ratio change, % of 0.32 <= 0.78
- Positive: Return on assets ratio (scaled to [-100,100]) of 10.89 > 6.06
- Negative: Industry operating cash flow per share per price (median), % of 1.51 <= 5.46
Short-term MASI quotes
Long-term MASI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-28 | 2026-01-03 |
|---|---|---|---|
| Operating Revenue | $2,048.10MM | $2,094.40MM | $1,524.10MM |
| Operating Expenses | $1,911.60MM | $2,361.10MM | $1,214.10MM |
| Operating Income | $136.50MM | $-266.70MM | $310.00MM |
| Non-Operating Income | $-48.40MM | $-38.60MM | $-37.40MM |
| Interest Expense | $50.30MM | $0.00MM | $0.00MM |
| R&D Expense | $175.20MM | $182.20MM | $126.40MM |
| Income(Loss) | $88.10MM | $-305.30MM | $272.60MM |
| Taxes | $6.60MM | $-0.40MM | $64.90MM |
| Other Income(Loss) | $0.00MM | $-321.10MM | $-359.20MM |
| Net Income(Loss)* | $81.50MM | $-304.90MM | $-151.50MM |
| Stockholders Equity | $1,364.80MM | $1,051.90MM | $721.20MM |
| Inventory | $545.00MM | $459.20MM | $380.30MM |
| Assets | $3,041.50MM | $2,625.70MM | $1,698.90MM |
| Operating Cash Flow | $94.10MM | $196.40MM | $217.80MM |
| Capital expenditure | $87.70MM | $51.10MM | $19.40MM |
| Investing Cash Flow | $-81.20MM | $-51.20MM | $275.10MM |
| Financing Cash Flow | $-57.10MM | $-125.60MM | $-520.70MM |
| Earnings Per Share** | $1.54 | $-5.72 | $-2.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.